Preferred
(EDT)
Other
Synthetic Biology: Industry Perspective
Targeting Metabolic Diseases with Synthetic Biotic Medicines
10:00 AM - 10:25 AM EDT
Tuesday, May 4, 2021Speaker
David Hava, PhD
Synlogic, Inc.
Synthetic Biology: Industry Perspective
Expanding the Synthetic Capabilities of Yeast
10:25 AM - 10:50 AM EDT
Tuesday, May 4, 2021Speaker
Virginia Cornish, PhD
Columbia University
Synthetic Biology: Industry Perspective
Precise Targeting of Acute Myeloid Leukemia with OR / NOT Logic-Gated Gene Circuits in CAR-NK Cells
10:50 AM - 11:15 AM EDT
Tuesday, May 4, 2021Speaker
Gary Lee, PhD
Senti Biosciences
Synthetic Biology: Industry Perspective
Coffee Break
11:15 AM - 11:40 AM EDT
Tuesday, May 4, 2021Synthetic Biology: Industry Perspective
Short Talk: Engineered T Cells Directed at Tumors with Defined Allelic Loss
11:40 AM - 11:55 AM EDT
Tuesday, May 4, 2021Speaker
Breanna DiAndreth, PhD
A2 Biotherapeutics, Inc.
Synthetic Biology: Industry Perspective
Short Talk: Machine Learning Models for Predictive Bioengineering
11:55 AM - 12:10 PM EDT
Tuesday, May 4, 2021Speaker
Michael Fero, PhD
TeselaGen Biotechnology
Synthetic Biology: Industry Perspective
Short Talk: Engineering Reversible Logic Based Synthetic Gene Circuits in Living Bacteria and Its Potential Application in Therapeutic Delivery to Human Cancer Cells
12:10 PM - 12:25 PM EDT
Tuesday, May 4, 2021Speaker
Rajkamal Srivastava, MS
Saha Institute of Nuclear Physics, HBNI
Synthetic Biology: Industry Perspective
Short Talk: Anti-Arrhythmic Ion Channel Engineering Enables Self-Restoration of Cardiac Rhythm: Towards Synthetic Biomedicine in Cardiology
12:25 PM - 12:40 PM EDT
Tuesday, May 4, 2021Speaker
Tim De Coster, PhD
Leiden University Medical Center
Synthetic Biology: Industry Perspective
